TABLE 1 .
Patient sample | CFUa | Western blotb | ELISA titerc |
---|---|---|---|
Urined | |||
UID1 | 2.25 × 104 | − | 8 |
UID2 | >1 × 105 | + | 1,300 |
UID3 | 7.5 × 104 | + | 59 |
UID4 | 1.2 × 104 | − | 2.8 |
UID5 | >1 × 105 | + | 200 |
UID6 | 3.5 × 103 | − | 0 |
UID7 | >1 × 105 | + | 550 |
UID9 | <1 × 103 | − | 0 |
UID10 | 1 × 103 | − | 0 |
UID12 | 1 × 103 | − | 0 |
Serumd | |||
MSID1 | + | − | 16 |
MSID2 | + | − | 0 |
MSID3 | + | − | 20 |
MSID4 | + | − | 9.8 |
MSID5 | + | − | 0 |
MSID6 | + | − | 2.5 |
MSID7 | + | − | 0 |
MSID8 | + | − | 0 |
MSID9 | + | − | 4.6 |
MSID10 | + | − | 0 |
Quantitative cultures were done with urine samples, and results are reported as the number of CFU/ml. Blood cultures (serum) are reported only as positive or negative. All samples were filtered before analysis for antigen.
Western blotting was prepared from patient urine or serum and was probed with the CPS MAb 3C5.
The ELISA titer is the highest dilution of patient urine or serum that produced an OD450 of ≥0.5 in an antigen capture ELISA prepared from MAb 3C5.
The serum and urine samples were collected from different patients.